Company Profile For Astellas Pharma Inc.

Astellas Pharma Inc. (4503.T) (Tokyo Stock Exchange)

sector: Healthcare · industry: Pharmaceuticals - Generic & Specialty ·

As of 4:28am GMT

3,130JPY

Price Change

-40

Percent Change

-1.26%

Analyst Recommendations

Overview

Astellas Pharma Inc. is a Japan-based company engaged in the manufacturing and sale of pharmaceuticals and related products. The Company offers its pharmaceuticals to both domestic and overseas markets including Japan, North America, Europe and Asia. In addition, the Company is also engaged in real estate business. The Company has 64 consolidated subsidiaries and two associated companies.

Quick Financial Synopsis

BRIEF: For the six months ended 30 September 2009, Astellas Pharma Inc.'s revenues increased less than 1% to Y494.64B. The Company's net income decreased 8% to Y83.49B. Revenues reflect higher sales volume of products in Japan and North America markets. Net income is offset by a higher percentage of cost of sales, decreased gains on sale of fixed assets, as well as the presence of Y3.65B foreign exchange losses.